Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen H Beresini

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|July 26, 2002
Selective alpha4beta7 integrin antagonists and their potential as antiinflammatory agentsNathan J P Dubree, Dean R Artis, Georgette Castanedo, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Solid-phase synthesis of dual alpha4beta1/alpha4beta7 integrin antagonists: two scaffolds with overlapping pharmacophoresGeorgette M Castanedo, Fredrick C Sailes, Nathan J P Dubree, et al.
Nature Structural & Molecular Biology|August 22, 2017
Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonistsYingnan Zhang, Mark Ultsch, Nicholas J Skelton, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout CellsMichael F T Koehler, Philippe Bergeron, Elizabeth M Blackwood, et al.
Cancer Research|August 19, 2017
Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate CancerLingyan Jin, Jesse Garcia, Emily Chan, et al.
Nature Communications|December 11, 2025
Chemically-induced degradation of the endoplasmic-reticulum stress sensor IRE1 by a VHL-recruiting chimeraJin Du, Elisia Villemure, Matthew Johnson, et al.
Nature Communications|December 15, 2020
Activation of the IRE1 RNase through remodeling of the kinase front pocket by ATP-competitive ligandsElena Ferri, Adrien Le Thomas, Heidi Ackerly Wallweber, et al.
Bioorganic & Medicinal Chemistry Letters|November 25, 2017
Design and synthesis of a biaryl series as inhibitors for the bromodomains of CBP/P300Kwong Wah Lai, F Anthony Romero, Vickie Tsui, et al.
Journal of Medicinal Chemistry|May 15, 2024
Discovery of Potent, Selective, and Orally Available IRE1α Inhibitors Demonstrating Comparable PD Modulation to IRE1 Knockdown in a Multiple Myeloma ModelMarie-Gabrielle Braun, Avi Ashkenazi, Ramsay E Beveridge, et al.
Journal of Medicinal Chemistry|November 21, 2017
A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) InhibitorsSarah M Bronner, Jeremy Murray, F Anthony Romero, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|July 26, 2002
Selective alpha4beta7 integrin antagonists and their potential as antiinflammatory agentsNathan J P Dubree, Dean R Artis, Georgette Castanedo, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Solid-phase synthesis of dual alpha4beta1/alpha4beta7 integrin antagonists: two scaffolds with overlapping pharmacophoresGeorgette M Castanedo, Fredrick C Sailes, Nathan J P Dubree, et al.
Nature Structural & Molecular Biology|August 22, 2017
Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonistsYingnan Zhang, Mark Ultsch, Nicholas J Skelton, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout CellsMichael F T Koehler, Philippe Bergeron, Elizabeth M Blackwood, et al.
Cancer Research|August 19, 2017
Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate CancerLingyan Jin, Jesse Garcia, Emily Chan, et al.
Nature Communications|December 11, 2025
Chemically-induced degradation of the endoplasmic-reticulum stress sensor IRE1 by a VHL-recruiting chimeraJin Du, Elisia Villemure, Matthew Johnson, et al.
Nature Communications|December 15, 2020
Activation of the IRE1 RNase through remodeling of the kinase front pocket by ATP-competitive ligandsElena Ferri, Adrien Le Thomas, Heidi Ackerly Wallweber, et al.
Bioorganic & Medicinal Chemistry Letters|November 25, 2017
Design and synthesis of a biaryl series as inhibitors for the bromodomains of CBP/P300Kwong Wah Lai, F Anthony Romero, Vickie Tsui, et al.
Journal of Medicinal Chemistry|May 15, 2024
Discovery of Potent, Selective, and Orally Available IRE1α Inhibitors Demonstrating Comparable PD Modulation to IRE1 Knockdown in a Multiple Myeloma ModelMarie-Gabrielle Braun, Avi Ashkenazi, Ramsay E Beveridge, et al.
Journal of Medicinal Chemistry|November 21, 2017
A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) InhibitorsSarah M Bronner, Jeremy Murray, F Anthony Romero, et al.
Pageof 3